The role of HLA-typing in transplantation of hematopoietic stem cells

Home/2017, Vol. 5, No. 2/The role of HLA-typing in transplantation of hematopoietic stem cells

Cell and Organ Transplantology. 2017; 5(2):159-163.
DOI: 10.22494/COT.V5I2.74

The role of HLA-typing in transplantation of hematopoietic stem cells

Khomenko V. I.
Kyiv Center of Bone Marrow Transplantation, Kyiv, Ukraine

The system of human leukocyte antigen (HLA) and HLA-typing were used to match a potential donor with a recipient for allogeneic hematopoietic stem cell transplantation (HSCT). The HLA matching between donor and recipient is key role in allogeneic HSCT. The mismatch of HLA can cause graft rejection, graft-versus-host disease and decrease survival in patients receiving grafts from both related and unrelated donors. The adverse HLA effect on the outcome depends on the total number of mismatched alleles/loci and the resolution level of the mismatch (antigen or allele level).
Thus, the final choice of compatible donor-recipient pairs should be based on high resolution molecular-genetic methods of HLA-typing. Serologic and molecular genetic methods of low resolution HLA-typing, which are cheaper than HLA-typing high-resolution, should be used for donor screening studies. HSCT from a fully compatible donor, matched high-resolution HLA-typing methods gives better results than from partially compatible. In some clinical circumstances, a partially compatible donor may be as effective as fully compatible. The selection of such a donor, taking into account the controversy of data from various literary sources, should be based on own research and experience. Creation and development of a Ukrainian database of donors with the HLA-haplotype specific to the indigenous population will make search of matching pairs of donor recipients more effective and cost-effective.

Key words: allogeneic hematopoietic stem cell transplantation (HSCT); human leucocyte antigens; HLA-typing

Full Text PDF (eng) Full Text PDF (ua)

1. Nowak J. Role of HLA in hematopoietic SCT. Bone Marrow Transplantation. 2008; 42: 71-76.
2. Morichima Y, Kashiwase K, Matsuo K, et al. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood. 2015; 125(7): 1189-1197.
PMid:25519752 PMCid:PMC4326776
3. Kekre N, Antin J. Hematopoietic stem cell transplantation donor sources in the 21st century: Сhoosing the ideal donor when a perfect match doesn’t exist. Blood. 2014; 124(3): 334-343.
4. Park M, Seo JJ. Role of HLA in Hematopoietic Stem Cell Transplantation. Bone Marrow Research. 2012; doi: 10.1155/2012/680841.
5. Kuzmich EV, Alyansky AL, Ivanova NE. Analiz rezul’tatov allogennoy transplantatsii gemopoeticheskikh stvolovykh kletok v zavisimosti ot stepeni HLA-podbora patsienta i nerodstvennogo donora [Analysis of the results of allogeneic transplantation of hematopoietic stem cells depending on the degree of HLA selection of the patient and unrelated donor]. Onkogematologiya – Oncohematology. 2014; 9(3): 25-31. [In Russian]
6. Bubnova LN, Pavlova IE, Glazanova TV, et al. Registry donorov gemopoeticheskikh stvolovykh kletok [Donor Register of hematopoietic stem cell]. Biomeditsinskiy zhurnal – Biomedical Journal 2015; 16: 751-758.
7. Makarenko OA, Alyanskiy AL, Ivaniva NE. Effektivnost’ poiska nerodstvennogo donora gemopoeticheskikh stvolovykh kletok c pomoshch’yu rossiyskoy poiskovoy sistemy Bone Marrow Donor Search: opyt NII detskoy onkologii, gematologii i transplantologii im. R. M. Gorbachevoy [Effectiveness of Search for an Unrelated Donor of Hematopoietic Stem Cells using Russian Date Base «Bone Marrow Donor Search»: Experience of Raisa Gorbacheva Memorial Institute for Children Oncology, Hematology and Transplantation]. Klinicheskaya onkogematologiya – Clinical oncohematology. 2017; 10(1): 39-44. [In Russian]
8. Afanasiev BV, Zubarovskaya LS, Moiseev IS. Allogennaya transplantatsiya gemopoeticheskikh stvolovykh kletok u detey: nastoyashchee, problemy, perspektivy [Afanasiev BV, Zubarovskaya LS, Moiseev IS. Allogeneic hematopoietic stem cell transplantation in children: now, problems and prospects]. Rossiyskiy zhurnal detskoy gematologii i onkologii – Russian Journal of Children Hematology and Oncology. 2015; 2(2): 28-42. [In Russian]
9. Passweg JR, Baldomero H, Bader P, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplantation. 2017; 52: 811-817.
PMid:28287639 PMCid:PMC5467246
10. Passweg JR, Baldomero H, Bader P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplantation. 2016; 51: 786-792.
PMid:26901709 PMCid:PMC4895175
11. Loginova MA, Paramonov IV, Trofimova NP. Neodnoznachnosti pri provedenii HLA-tipirovaniya po tekhnologi SSO i popytka ikh razresheniya [Ambiguity in HLA-typing with SSO technology and attempting to resolve them]. Vestnik transplantologii i iskusstvennykh organov – Russian Journal of Transplantology and Artificial Organs. 2010; 12(4): 33-38. [In Russian]
12. Shaw BE, Arguello R, Garcia-Sepulveda CA, et al. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. British Journal of Haematology. 2010; 150: 251-258.
13. Balint B, Pavlovic M, Todorovic M. Recent strategies vs. challenges in stem cell-based grafting: from innovative research to clinical practice. Bilt Transfuziol. 2011; 57(1-2): 9-25.
14. Bone Marrow Donor Worldwide, Stem Cell Donor Registries Statistics. Available:
15. Tiercy JM. Unrelated Hematopoietic Stem Cell Donor Matching Probability and Search Algorithm. Bone Marrow Research. 2012; 2012. 8 p.
16. Elmaagacli AH. Unrelated transplantation: donors issues. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi. 08 – 10 Mart 2012, Antalya. Available:
17. Bergstrom T, Garratt R, Sheehan-Connor D. One Chance in a Million: Altruism and the Bone Marrow Registry. Departmental Working Papers, Department of Economics, UCSB, University of California, Santa Barbara, 2008. 41 p.
18. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007; 110: 4576-4583.
19. Gratwohl A. The EBMT risk score. Bone Marrow Transplantation. 2012; 47: 749-56.
20. Crocchiolo R, Ciceri F, Fleischhauer K, et al. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplantation. 2009; 44: 571-577.
21. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002; 99: 4200-4206.
22. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004; 104: 1923-1930.

Khomenko VI. The role of HLA-typing in transplantation of hematopoietic stem cells. Cell and Organ Transplantology. 2017; 5(2):159-163. doi:10.22494/cot.v5i2.74

Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.